Other conditions

322 articles:
by Mary Sco.

The war raging in your body: These little-known immune cells may prevent severe COVID

Infectious diseases were once the greatest threat to human survival. Today it is not necessarily the infection itself but rather the immune system’s response to the infection that dictates the survival of the fittest.

by Aleksandra Nasteska Edward Riachy

A low carbohydrate diet can treat diabetes better … and save us money

The key to the diabetes crisis is well within our reach. We can win the fight against diabetes by embracing a low-carbohydrate diet as the first-line medical nutrition treatment.

by Catharine Chambers Nicole Naimer Maddi Dellplain

The Faces & Phases of COVID-19

The Faces/Phases Project is a portrait of the COVID-19 pandemic in Canada. Through a series of data visualizations, we cover the first two years of the pandemic.

by Stephanie Ragganandan

The diabetes epidemic in South Asian communities will continue until we shift to prevention

In Canada, South Asian communities are at a higher risk of developing Type 2 diabetes compared to the general population. As a result, South Asian populations experience significant morbidity and mortality.

by Natasha Correa Samira Jeimy

‘There aren’t many options for people like me’: A Q&A on living with food allergies

Rates of food allergy have increased in recent decades. 9 per cent of Canadians now report having a food allergy.

by Kevin Liang

MDI asthma inhalers come under scrutiny over heavy carbon cost

Small amounts of the propellants used in the familiar blue and orange inhalers can have an “outsized” climate footprint. Now there is a growing call for patients to switch to low-carbon dry powder alternatives.

by Stephanie Keeling

The carbon cost of clicking for health

The ease-of-use that has made autoinjectors a multi-billion-dollar global industry has increased the carbon dioxide footprint that comes with making them by the tens of millions.

by Colleen Fuller

History matters – a century after insulin’s discovery, we’re going backwards

As a Canadian with Type 1 diabetes I’m dismayed by the way pharmaceutical companies have driven up insulin prices, created a global oligarchy and increased the burden on those who need this life-giving medicine.

by Michael Fralick John Fralick

Episode 30 – SGLT2 inhibitors and GLP-1 agonists in Diabetes

5 of 17